Aurobindo Pharma slipped 2.60% to Rs 1,470.45 after US Food and Drug Administration (USFDA) issued 10 observations to the company’s wholly owned subsidiary, Apitoria Pharma’s API manufacturing facility situated in Telangana.
| Subscribe To Our Free Newsletter |
